Guava Technologies
Founded Year
1998Stage
Acquired - II | AcquiredTotal Raised
$65MAbout Guava Technologies
Guava Technologies aims to provide Personal Cell Analysis (PCA) products that have broad applications in life science cell biology research & development . Unlike the matured market for gene-based products, the cell analysis market is still in the early stage of growth. Similar to the Apple Personal Computer which expanded the market by making computing accessible to professional end users outside of the mainframe environment, Guava's affordable designed cell analysis system aims to provide hands-on access to cell biologists outside of the centralized core cell analysis labs.
Missing: Guava Technologies's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Guava Technologies's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Guava Technologies
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Guava Technologies is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Guava Technologies Patents
Guava Technologies has filed 2 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
4/10/2007 | 7/21/2009 | Flow cytometry, Cell biology, Hematology, Blood tests, Medical tests | Grant |
Application Date | 4/10/2007 |
|---|---|
Grant Date | 7/21/2009 |
Title | |
Related Topics | Flow cytometry, Cell biology, Hematology, Blood tests, Medical tests |
Status | Grant |
Latest Guava Technologies News
Aug 30, 2013
(Page 1 of 1) Millipore will pay $22.6 million to acquire Guava Technologies, a provider of benchtop cell-analysis systems. The acquisition follows the distribution and co-development partnership the two companies entered in March 2008 to bring flow cytometry to cellular biologists. “Our vision is to make flow cytometry less expensive, easier to use, and more accessible for all research scientists,” says Jonathan DiVincenzo, president of Millipore’s bioscience division. “Additionally, by developing kits that are optimized for key research areas such as stem cell research, cancer biology, cell health, and biomarker discovery, scientists will no longer need to source reagents and develop their own assays. We exceeded our targets for placing Guava instruments in 2008 and we are excited about further increasing the adoption of our flow cytometry platform by accelerating our investments in R&D, sales, and marketing.” Guava’s technology may be used to develop new products for the process monitoring tools segment of Millipore’s bioprocess division. The company expects to maintain Guava’s manufacturing and commercial operations in Hayward, CA. Guava generated approximately $22 million in sales during 2008. The transaction is expected to be slightly accretive to Millipore’s non-GAAP earnings per share this year and is expected to close in the next two weeks. ---
Guava Technologies Frequently Asked Questions (FAQ)
When was Guava Technologies founded?
Guava Technologies was founded in 1998.
Where is Guava Technologies's headquarters?
Guava Technologies's headquarters is located at 25801 Industrial Boulevard, Hayward.
What is Guava Technologies's latest funding round?
Guava Technologies's latest funding round is Acquired - II.
How much did Guava Technologies raise?
Guava Technologies raised a total of $65M.
Who are the investors of Guava Technologies?
Investors of Guava Technologies include Luminex, MilliporeSigma, Hercules Capital, Skyline Ventures, ProQuest Investments and 14 more.
Who are Guava Technologies's competitors?
Competitors of Guava Technologies include Fluxion Biosciences, Primorigen Biosciences, CytoBioscience, Hepregen, Cellomics and 11 more.
Compare Guava Technologies to Competitors
Plectix BioSystems Inc. is focussed on approaches for overcoming challenges faced by biologists in the complex world of cell signaling.
IntelCell markets a product platform engineered to modernize research techniques for cell and tissue growth. The company's first product, Cell Drive, replaces traditional cell culture equipment by providing an unprecedented level of usability and sophistication for the user. For scientists whose research depends upon live cell culture, Cell Drive aims to offer a compact, precision, cell growth system that increases experimental control, aims to improve sterility, aims to provide digitization of data and methods, and aims to reduce human error and labor costs.
CellAura Technologies is a spin out company from the University of Nottingham, combining world-renowned expertise in the fields of synthetic chemistry and molecular pharmacology to produce high quality fluoresent G-protein coupled receptor ligands for use in molecular pharmacology and imaging at the single cell level.
CellCura, Inc. is a company dedicated to the development of equipment and products for use in assisted reproductive technology (ART) and stem cell research.
DC Biosciences, formerly Dundee Cell Products, provides pharmaceutical and biotech companies with novel technologies and proteomics services to accelerate the development of safer drugs.
Areta International was founded, with totally private financial support, by Dr. Maria Luisa Nolli in autumn 1999 as a spin-off of cell biology Laboratories of Lepetit Research Center, part of multinational companies, where she had a twenty years experience as scientist and team leader. nnThe company was born to cover the gap existing between the excellent basic research and the poor development of discoveries, with a view of helping customers to transform research projects in new potential biodrugs. nn nn
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.